CTEP Branches and Offices
Staff, Pictures and Bios
Meg Mooney, MD, MS, Branch Chief, CIB
Meg Mooney, MD, MS, is the Associate Director of the Cancer Therapy Evaluation Program (CTEP), Division of Cancer Treatment and Diagnosis (DCTD), at the National Cancer Institute (NCI), and she is also the Chief of the Clinical Investigations Branch (CIB) in CTEP. More…
Malcolm A. Smith, MD, PhD, Associate Branch Chief for Pediatric Oncology
Dr. Smith is Associate Branch Chief, Pediatrics in the Clinical Investigations Branch [Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI)]. More…
Carmen Allegra, MD, Head — GI Cancer Therapeutics
Dr. Carmen Allegra joined the Clinical Investigations Branch (CIB), CTEP, DCTD in April 2016 to provide expertise and oversight of the GI cancers clinical trials portfolio under an interagency agreement between NCI and the University of Florida Health where he is Chief of Oncology and Hematology, Department of Medicine. More…
Andrea M. Denicoff, RN, MS, ANP, Head, NCTN Clinical Trials Operations & Scientific Liaison, Patient Reported Outcomes (PROs)
Andrea Denicoff is a Nurse Consultant in the Clinical Investigations Branch within the Cancer Therapy Evaluation Program (CTEP) in the Division of Cancer Treatment & Diagnosis at the National Cancer Institute (NCI). She serves as the Head of Clinical Trials Operations for the NCI's National Clinical Trials Network (NCTN). More…
Lori A. Henderson, PhD, Chief, Clinical Grants and Contracts Branch and Program Director
Dr. Lori Henderson is the Chief, Clinical Grants and Contacts Branch and a Program Director who joined the Clinical Investigations Branch in CTEP in 2019. She manages a portfolio of clinical grants covering the hematologic malignancies as well as activities related to the NCI collaboration with the National Heart, Lung, and Blood Institute on the Blood and Marrow Transplant Clinical Trials Network and other projects in the hematologic and transplant fields. More…
Elise C. Kohn, MD, Head — Gynecologic Cancer Therapeutics
To promote scientifically driven and practice-changing trials, Dr. Kohn reviews, coordinates, and oversees development and execution of phase 2-3 trials in gynecologic cancers and gastrointestinal neuroendocrine cancers. She also provides disease expertise for early phase trials in these cancers. Dr. Kohn also applies her expertise to the oversight and guidance of the NCTN Core Correlative Science Committee (CCSC). More…
Larissa Korde, MD, Head — Breast Cancer and Melanoma Therapeutics
Dr. Larissa Korde joined the Clinical Investigations Branch, CTEP, DCTD in September 2016 and provides expertise and oversight of the breast cancer and melanoma clinical trials portfolios. Dr. Korde is well known to the NCTN Program community and NCI. More…
Richard F. Little, MD, Head — Hematologic, HIV, and Stem Cell Therapeutics
Dr. Richard F. Little joined CTEP in 2007 as head of the therapeutics section for Hematologic and AIDS-related Cancers and Hematopoietic Stem Cell Transplant. His focus is to oversee, review, and coordinate the NCI-sponsored late phase cancer treatment trials in these diseases. More…
Shakun Malik, MD, Head — Thoracic Cancer Therapeutics
Dr. Shakun Malik joined the National Cancer Institute's (NCI) Cancer Therapy Evaluation Program in November 2013 as the head of thoracic oncology therapeutics. Her goal is to facilitate lung cancer research. Prior to joining CTEP, Dr. Malik worked at the U.S. Food and Drug Administration (FDA), where she gained valuable experience in understanding the regulatory pathways that make drugs available to patients. More…
Bhupinder Mann, MBBS, Head — Genitourinary and Brain Cancer Therapeutics
Dr. Bhupinder Mann joined the Clinical Investigations Branch at CTEP in September 2008. He has the Genitourinary and the Adult Brain Cancer therapeutic clinical trials portfolio. He is the assigned CIB scientific liaison to the NCTN NRG group. More…
Grace Mishkin, PhD, MPH, Health Science Policy Analyst
Grace Mishkin joined the Clinical Investigations Branch in CTEP as a Public Health Analyst in July 2016. She provides operational support for NCI's National Clinical Trials Network and coordinates several cross-cutting projects around clinical trials at NCI. More…
Nita L. Seibel, MD, Head — Pediatric Solid Tumors
Dr. Nita L. Seibel, a board certified pediatric hematologist-oncologist is the head of the Pediatric Solid Tumor Therapeutics in the Clinical Investigations Branch of the Cancer Therapy and Evaluation Program of the National Cancer Institute. More…
In Memory of William C. Timmer, PhD, Program Director
It is with great sorrow that we announce the passing of Dr. William C. Timmer in late December 2021. Dr. Timmer joined CTEP as a Program Director in the Clinical Grants and Contracts Branch in 2007. In 2018, he became a Program Director in the Clinical Investigations Branch. He managed a portfolio of clinical grants involving brain, head and neck, lung, liver, colorectal, pancreatic, and sarcoma cancers, plus neuroblastoma, retinoblastoma and neurofibromatosis. More…
About the Branch Chief
Meg Mooney, MD, MS, is the Associate Director of the Cancer Therapy Evaluation Program (CTEP), Division of Cancer Treatment and Diagnosis (DCTD), at the National Cancer Institute (NCI), and she is also the Chief of the Clinical Investigations Branch (CIB) in CTEP.
More…